A decision will be made on January 6 on the commercialization of the Moderna vaccine in Europe.



[ad_1]

This could be the second vaccine to be licensed in the EU.

The European Medicines Agency (EMA) will decide on January 6, six days ahead of schedule, whether to recommend allowing Moderna’s vaccination against the coronavirus, the agency announced in Amsterdam on Thursday.

The decision was originally scheduled for January 12, but the US pharmaceutical company delivered the last part of the dossier earlier than expected on Thursday. These figures already refer to production for the European market, writes MTI, according to the EMA.

The Moderna vaccine may be the second to be licensed in the European Union. The Pfizer / BioNTech coronavirus vaccine could be approved by the EU next week. Ursula von der Leyen, the president of the European Commission said on Thursday that the EU member states will begin to vaccinate the population against the coronavirus from December 27.

The Pfizer / BioNTech vaccine has already been emergency approved in Britain, the United States and Canada, increasing pressure on the European Medicines Agency, especially from Germany, wrote the French news agency AFP.



[ad_2]